by Sue Robbins | Dec 14, 2020 | Migraine
Monoclonal antibodies and small-molecule antagonists that target CGRP or its receptor are already having a big impact on migraine. But they have the potential to do so much more. Peter Goadsby sat in the audience, intrigued. The Australian medical student had come to...
by Sue Robbins | Dec 12, 2020 | Migraine
Scientists are trying to work out why attacks become more and more frequent in some people — and how to reverse the process. Len Barbieri started getting migraine headaches when he was 9 years old, although it was many years before they were labelled as such. The...
by Sue Robbins | Dec 9, 2020 | Migraine
Poor posture and long periods of inactivity can contribute to an increase in migraine frequency Whether it’s for work or school, many of us feel tied to our computer screens and desks. Long periods of sitting and increased time using technology can have negative...
by Sue Robbins | Dec 7, 2020 | Migraine
Understanding the relationship between migraine, depression and anxiety with Dawn Buse, PhD AHS: What do we know about the relationship between depression and migraine? DB: Depression and migraine share a common relationship, and one may actually come before the...
by Sue Robbins | Dec 6, 2020 | Migraine
The COVID?19 health emergency has led many Headache providers to transition to virtual care overnight without preparation. We review our experience and discuss tips to bring humanity to the virtual visits. Introduction Human presence is intrinsically...
